Related Experiment Video
Updated: Oct 5, 2025

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
SARS-CoV-2 targets the lysosome to mediate airway inflammatory cell death
Xiao Sun1, Jun Yu2,3,4, Sunny Hei Wong2,3,5
1Department of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong Administrative Region, China.
Abstract:
As the coronavirus disease 2019 (COVID-19) pandemic continues to wreak havoc, researchers around the globe are working together to understand how the responsible agent - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) damages the respiratory system and other organs. Macroautophagy/autophagy is an innate immune response against viral infection and is known to be manipulated by positive-strand RNA viruses, including SARS-CoV-2. Nevertheless, the link between autophagic subversion and cell death or inflammation in COVID-19 remains unclear. Emerging evidence suggests that SARS-CoV-2 could trigger pyroptosis, a form of inflammatory programmed cell death characterized by the activation of inflammasomes and CASP1 (caspase 1) and the formation of transmembrane pores by GSDMD (gasdermin D). In this connection, autophagic flux impairment is a known activator of inflammasomes. This prompted us to investigate if SARS-CoV-2 could target autophagy to induce inflammasome-dependent pyroptosis in lung epithelial cells.Abbreviations: ATP6AP1: ATPase H+ transporting accessory protein 1; CASP1: caspase 1; COVID-19: coronavirus disease 2019; GSDMD: gasdermin D; IL1B: interleukin 1 beta; IL18: interleukin 18; KRT 18: keratin 18; NLRP3: NLR family pyrin domain containing 3; NOD: nucleotide oligomerization domain; NSP6: non-structural protein 6; TFEB: transcription factor EB; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may trigger pyroptosis, a form of inflammatory cell death, by disrupting autophagy. This study investigates SARS-CoV-2
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- The coronavirus disease 2019 (COVID-19) pandemic, caused by SARS-CoV-2, necessitates understanding its pathogenic mechanisms.
- Autophagy is a crucial innate immune response against viral infections, often manipulated by RNA viruses like SARS-CoV-2.
- The precise relationship between SARS-CoV-2-induced autophagic dysfunction, cell death, and inflammation remains incompletely understood.
Purpose of the Study:
- To investigate whether SARS-CoV-2 targets autophagy to induce inflammasome-dependent pyroptosis in lung epithelial cells.
- To elucidate the role of autophagic flux impairment in SARS-CoV-2-mediated pyroptosis.
- To explore the potential link between viral-induced autophagy subversion and programmed cell death in COVID-19 pathogenesis.
Main Methods:
- Utilizing lung epithelial cell models infected with SARS-CoV-2.
- Assessing autophagic flux and its impairment by SARS-CoV-2 infection.
- Analyzing inflammasome activation, including caspase 1 (CASP1) and gasdermin D (GSDMD) cleavage.
- Quantifying pyroptotic cell death markers.
Main Results:
- SARS-CoV-2 infection leads to the impairment of autophagic flux in lung epithelial cells.
- Viral non-structural protein 6 (NSP6) is identified as a key factor in disrupting autophagic processes.
- SARS-CoV-2-induced autophagic impairment activates the NLRP3 inflammasome, leading to CASP1-dependent pyroptosis.
- GSDMD cleavage and pore formation are observed, indicating the execution of pyroptosis.
Conclusions:
- SARS-CoV-2 actively subverts autophagy to promote inflammasome activation and pyroptosis in lung epithelial cells.
- Autophagic flux impairment is a critical mechanism by which SARS-CoV-2 drives inflammatory cell death.
- Targeting autophagic pathways may represent a therapeutic strategy for managing COVID-19-associated lung injury.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pneumonia II: Pathophysiology
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

